A mutational analysis of the active site of human type II inosine 5′-monophosphate dehydrogenase

被引:19
作者
Futer, O [1 ]
Sintchak, MD [1 ]
Caron, PR [1 ]
Nimmesgern, E [1 ]
DeCenzo, MT [1 ]
Livingston, DJ [1 ]
Raybuck, SA [1 ]
机构
[1] Vertex Pharmaceut Inc, Cambridge, MA 02139 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY | 2002年 / 1594卷 / 01期
关键词
inosine monophosphate dehydrogenase; site-directed mutagenesis; X-ray structure; mycophenolic acid; active site; mechanism of catalysis;
D O I
10.1016/S0167-4838(01)00277-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The oxidation of IMP to XMP is the rate-limiting step in the de novo synthesis of guanine ribonucleotides. This NAD-dependent reaction is catalyzed by the enzyme inosine monophosphate dehydrogenase (IMPDH). Based upon the recent structural determination of IMPDH complexed to oxidized IMP (XMP*) and the potent uncompetitive inhibitor mycophenolic acid (MPA), we have selected active site residues and prepared mutants of human type II IMPDH. The catalytic parameters of these mutants were determined. Mutations G326A, D364A, and the active site nucleophile C331A all abolish enzyme activity to less than 0.1% of wild type. These residues line the IMP binding pocket and are necessary for correct positioning of the substrate, Asp364 serving to anchor the ribose ring of the nucleotide. In the MPA/NAD binding site, significant loss of activity was seen by mutation of any residue of the triad Arg322, Asn303, Asp274 which form a hydrogen bonding network lining one side of this pocket. From a model of NAD bound to the active site consistent with the mutational data, we propose that these resides are important in binding the ribose ring of the nicotinamide substrate. Additionally, mutations in the pair Thr333, Gln441, which lies close to the xanthine ring, cause a significant drop in the catalytic activity of IMPDH. It is proposed that these residues serve to deliver the catalytic water molecule required for hydrolysis of the cysteine-bound XMP* intermediate formed after oxidation by NAD. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:27 / 39
页数:13
相关论文
共 36 条
  • [1] IMMUNOSUPPRESSIVE AND OTHER EFFECTS OF MYCOPHENOLIC-ACID AND AN ESTER PRODRUG, MYCOPHENOLATE MOFETIL
    ALLISON, AC
    EUGUI, EM
    [J]. IMMUNOLOGICAL REVIEWS, 1993, 136 : 5 - 28
  • [2] PROBING THE ACTIVE-SITE OF HUMAN IMP DEHYDROGENASE USING HALOGENATED PURINE RIBOSIDE 5'-MONOPHOSPHATES AND COVALENT MODIFICATION REAGENTS
    ANTONINO, LC
    STRAUB, K
    WU, JC
    [J]. BIOCHEMISTRY, 1994, 33 (07) : 1760 - 1765
  • [3] INOSINE 5'-PHOSPHATE DEHYDROGENASE . KINETIC MECHANISM AND EVIDENCE FOR SELECTIVE REACTION OF 6-CHLORO ANALOG OF INOSINE 5'-PHOSPHATE WITH A CYSTEINE RESIDUE AT INOSINE 5'-PHOSPHATE SITE
    BROX, LW
    HAMPTON, A
    [J]. BIOCHEMISTRY, 1968, 7 (07) : 2589 - &
  • [4] BRUNGER AT, 1993, XPLOR SYSTEM XRAY CR
  • [5] Crystal structure of human type II inosine monophosphate dehydrogenase: Implications for ligand binding and drug design
    Colby, TD
    Vanderveen, K
    Strickler, MD
    Markham, GD
    Goldstein, BM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (07) : 3531 - 3536
  • [6] COLLART FR, 1992, CANCER RES, V52, P5826
  • [7] Crystal Structure of the protein drug urate oxidase-inhibitor complex at 2.05 angstrom resolution
    Colloch, N
    ElHajji, M
    Bachet, B
    LHermite, G
    Schiltz, M
    Prange, T
    Castro, B
    Mornon, JP
    [J]. NATURE STRUCTURAL BIOLOGY, 1997, 4 (11) : 947 - 952
  • [8] DAYTON JS, 1994, J IMMUNOL, V152, P984
  • [9] Species-specific inhibition of inosine 5′-monophosphate dehydrogenase by mycophenolic acid
    Digits, JA
    Hedstrom, L
    [J]. BIOCHEMISTRY, 1999, 38 (46) : 15388 - 15397
  • [10] Inhibition of IMPDH by mycophenolic acid: Dissection of forward and reverse pathways using capillary electrophoresis
    Fleming, MA
    Chambers, SP
    Connelly, PR
    Nimmesgern, E
    Fox, T
    Bruzzese, FJ
    Hoe, ST
    Fulghum, JR
    Livingston, DJ
    Stuver, CM
    Sintchak, MD
    Wilson, KP
    Thomson, JA
    [J]. BIOCHEMISTRY, 1996, 35 (22) : 6990 - 6997